These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 16517276)

  • 1. Testicular germ-cell cancer.
    Horwich A; Shipley J; Huddart R
    Lancet; 2006 Mar; 367(9512):754-65. PubMed ID: 16517276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cell biology of testicular germ cell tumors.
    Chieffi P; Franco R; Portella G
    Int Rev Cell Mol Biol; 2009; 278():277-308. PubMed ID: 19815181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
    Wheater MJ; Manners J; Nolan L; Simmonds PD; Hayes MC; Mead GM
    BJU Int; 2011 Dec; 108(11):1794-9. PubMed ID: 21627751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metachronous bilateral testicular germ cell tumors: report of two cases.
    James FV; Kumar A; Jayaprakash PG; Mathews A
    J Cancer Res Ther; 2009; 5(3):206-7. PubMed ID: 19841564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours.
    Cullen M
    Ann Oncol; 2012 Sep; 23 Suppl 10():x342-8. PubMed ID: 22987989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and predictive factors in testicular cancer.
    Facchini G; Rossetti S; Berretta M; Cavaliere C; D'Aniello C; Iovane G; Mollo G; Capasso M; Della Pepa C; Pesce L; Facchini S; Imbimbo C; Pisconti S
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3885-3891. PubMed ID: 31115016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
    Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
    J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
    Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
    J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage II seminomas and nonseminomas.
    Chung PW; Bedard P
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):529-41,viii. PubMed ID: 21570607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumors of the Testis: Morphologic Features and Molecular Alterations.
    Howitt BE; Berney DM
    Surg Pathol Clin; 2015 Dec; 8(4):687-716. PubMed ID: 26612222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Embryonal germ cells and germ cell tumors].
    Biermann K; Heukamp LC; Nettersheim D; Steger K; Zhou H; Franke FE; Guetgemann I; Sonnack V; Brehm R; Berg J; Bastian PJ; Müller SC; Wang-Eckert L; Schorle H; Büttner R
    Verh Dtsch Ges Pathol; 2007; 91():39-48. PubMed ID: 18314594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular germ cell tumors: biology and clinical update.
    Mannuel HD; Mitikiri N; Khan M; Hussain A
    Curr Opin Oncol; 2012 May; 24(3):266-71. PubMed ID: 22343384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical presentation of testicular germinal cancer].
    Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
    Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
    Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo.
    Jostes S; Nettersheim D; Fellermeyer M; Schneider S; Hafezi F; Honecker F; Schumacher V; Geyer M; Kristiansen G; Schorle H
    J Cell Mol Med; 2017 Jul; 21(7):1300-1314. PubMed ID: 28026145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression levels of the IAP antagonists XAF1, Smac/DIABLO and HtrA2 in testicular germ cell tumours].
    Kempkensteffen C; Hinz S; Jäger T; Weikert S; Krause H; Schostak M; Christoph F; Strenziok R; Miller K; Schrader M
    Aktuelle Urol; 2008 Nov; 39(6):436-41. PubMed ID: 18979398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of "late" in the management of late relapse after treatment for a germ cell tumor.
    Toner GC
    J Clin Oncol; 2008 Dec; 26(34):5502-3. PubMed ID: 18936469
    [No Abstract]   [Full Text] [Related]  

  • 20. The chemosensitivity of testicular germ cell tumors.
    Voutsadakis IA
    Cell Oncol (Dordr); 2014 Apr; 37(2):79-94. PubMed ID: 24692098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.